Oppenheimer Initiates Coverage On PolyPid with Outperform Rating, Announces Price Target of $10
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Oppenheimer analyst Les Sulewski initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $10.
Oppenheimer analyst Les Sulewski initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $10.
